Latest Insider Transactions at Proassurance Corp (PRA)
This section provides a real-time view of insider transactions for Proassurance Corp (PRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROASSURANCE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROASSURANCE CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 23
2025
|
Noreen Dishart Executive VP/Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-11.06%
|
$57,155
$23.15 P/Share
|
May 23
2025
|
Noreen Dishart Executive VP/Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,987
+21.04%
|
$137,701
$23.15 P/Share
|
May 23
2025
|
Robert David Francis Pres Healthcare Pro. Liability |
SELL
Payment of exercise price or tax liability
|
Direct |
3,712
-15.01%
|
$85,376
$23.15 P/Share
|
May 23
2025
|
Robert David Francis Pres Healthcare Pro. Liability |
BUY
Exercise of conversion of derivative security
|
Direct |
8,765
+26.16%
|
$201,595
$23.15 P/Share
|
May 23
2025
|
Kevin Merrick Shook President of a Subsidiary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,236
-6.93%
|
$74,428
$23.15 P/Share
|
May 23
2025
|
Kevin Merrick Shook President of a Subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,686
+14.13%
|
$176,778
$23.15 P/Share
|
May 23
2025
|
Dana S Hendricks Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,256
-8.36%
|
$74,888
$23.15 P/Share
|
May 23
2025
|
Dana S Hendricks Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,686
+16.49%
|
$176,778
$23.15 P/Share
|
May 23
2025
|
Jeffrey Patton Lisenby Executive Vice-President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,256
-3.55%
|
$74,888
$23.15 P/Share
|
May 23
2025
|
Jeffrey Patton Lisenby Executive Vice-President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,686
+7.74%
|
$176,778
$23.15 P/Share
|
May 23
2025
|
Edward Lewis Rand Jr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,564
-4.74%
|
$288,972
$23.15 P/Share
|
May 23
2025
|
Edward Lewis Rand Jr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,666
+10.06%
|
$682,318
$23.15 P/Share
|
May 21
2025
|
Bruce D Angiolillo Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+10.32%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Staci Pierce Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+27.86%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Richard J Bielen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+27.86%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Maye Head Frei Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+11.59%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Scott C Syphax Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+14.0%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Katisha Terrell Vance Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+10.72%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Samuel A Di Piazza Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+8.36%
|
$94,323
$23.16 P/Share
|
May 21
2025
|
Fabiloa Cobarrubias Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+14.0%
|
$94,323
$23.16 P/Share
|
Feb 25
2025
|
Jeffrey Patton Lisenby Executive Vice-President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,771
-6.43%
|
$92,336
$16.13 P/Share
|
Feb 25
2025
|
Jeffrey Patton Lisenby Executive Vice-President |
BUY
Exercise of conversion of derivative security
|
Direct |
13,064
+6.92%
|
$209,024
$16.13 P/Share
|
Feb 25
2025
|
Kevin Merrick Shook President of a Subsidiary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,769
-12.88%
|
$92,304
$16.13 P/Share
|
Feb 25
2025
|
Kevin Merrick Shook President of a Subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,064
+13.18%
|
$209,024
$16.13 P/Share
|
Feb 25
2025
|
Edward Lewis Rand Jr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,905
-9.57%
|
$398,480
$16.13 P/Share
|
Feb 25
2025
|
Edward Lewis Rand Jr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,806
+10.46%
|
$940,896
$16.13 P/Share
|
Feb 25
2025
|
Robert David Francis Pres Healthcare Pro. Liability |
SELL
Payment of exercise price or tax liability
|
Direct |
4,647
-22.54%
|
$74,352
$16.13 P/Share
|
Feb 25
2025
|
Robert David Francis Pres Healthcare Pro. Liability |
BUY
Exercise of conversion of derivative security
|
Direct |
10,997
+22.2%
|
$175,952
$16.22 P/Share
|
Feb 25
2025
|
Dana S Hendricks Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,781
-15.62%
|
$92,496
$16.13 P/Share
|
Feb 25
2025
|
Dana S Hendricks Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,064
+15.64%
|
$209,024
$16.13 P/Share
|
Feb 25
2025
|
Noreen Dishart Executive VP/Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,888
-19.09%
|
$62,208
$16.13 P/Share
|
Feb 25
2025
|
Noreen Dishart Executive VP/Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,165
+21.12%
|
$162,640
$16.13 P/Share
|
Jul 01
2024
|
Edward Lewis Rand Jr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,066
-10.27%
|
$276,792
$12.2 P/Share
|
Jul 01
2024
|
Edward Lewis Rand Jr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,157
+19.72%
|
$661,884
$12.2 P/Share
|
May 23
2024
|
Bruce D Angiolillo Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+30.72%
|
$209,820
$15.57 P/Share
|
May 23
2024
|
Samuel A Di Piazza Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+25.49%
|
$195,832
$14.57 P/Share
|
May 23
2024
|
Staci Pierce Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,520
+50.0%
|
$91,280
$14.57 P/Share
|
May 23
2024
|
Fabiloa Cobarrubias Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+39.88%
|
$195,832
$14.57 P/Share
|
May 23
2024
|
Richard J Bielen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,520
+50.0%
|
$91,280
$14.57 P/Share
|
May 23
2024
|
Kedrick D Adkins Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+32.62%
|
$195,832
$14.57 P/Share
|
May 23
2024
|
Maye Head Frei Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+33.96%
|
$195,832
$14.57 P/Share
|
May 23
2024
|
Scott C Syphax Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+39.88%
|
$195,832
$14.57 P/Share
|
May 23
2024
|
Katisha Terrell Vance Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,988
+31.76%
|
$195,832
$14.57 P/Share
|
Mar 06
2024
|
Kevin Merrick Shook President of a Subsidiary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,414
-14.57%
|
$64,968
$12.36 P/Share
|
Mar 06
2024
|
Kevin Merrick Shook President of a Subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct |
12,106
+14.68%
|
$145,272
$12.36 P/Share
|
Mar 06
2024
|
Dana S Hendricks Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,004
-17.28%
|
$60,048
$12.36 P/Share
|
Mar 06
2024
|
Dana S Hendricks Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,090
+17.12%
|
$133,080
$12.36 P/Share
|
Mar 06
2024
|
Noreen Dishart Executive VP/Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,390
-18.98%
|
$28,680
$12.36 P/Share
|
Mar 06
2024
|
Noreen Dishart Executive VP/Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,147
+22.03%
|
$73,764
$12.36 P/Share
|
Mar 06
2024
|
Edward Lewis Rand Jr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,974
-8.62%
|
$191,688
$12.36 P/Share
|